000			01448nam a2200373 i 4500
001			000285006
003			UVAL
005			20240507121744.0
006			a|||||r|||| 00| 0
007			ta
008			221124t2014 ne a b 001 0 eng
020			_a9780123820303
040			_aDIBRA _bspa _cUVAL _erda
041	0		_aeng
082	0	4	_a615.19 _223
100	1		_aSilverman, Richard B., _eautor. _9237986.
245	1	4	_aThe organic chemistry of drug design and drug action / _cRichard B. Silverman, Mark W. Holladay.
250			_aThird edition.
264		1	_aAmsterdam ; _aBoston : _bElsevier/AP, Academic Press, is an imprint of Elsevier, _c[2014]
264		4	_c©2014
300			_axviii, 517 páginas : _bilustraciones (algunas en color). .
347			_2rda _atext file _bPDF
500			_aIncluye índice.
504			_aIncluye referencias bibliográficas.
505	0		_aIntroduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems.
650	1	4	_aQuímica bioorganica _9237987.
650	1	4	_aQUIMICA FARMACEUTICA _94699.
650		0	_aFarmacología molecular _9237988.
700	1		_aHolladay, Mark W., _e, autor. _9237989.
942			_2ddc _cBK
999			_c285006 _d285006